Abstract
This work evaluated the in vitro effect of thiazolidin-4-ones on the activity of AChE (total and isoforms) isolated from the cerebral cortex, hippocampus, and lymphocytes. Kinetic parameters were evaluated and molecular docking was performed. Our results showed that thiazolidinones derived from 4-(methylthio)benzaldehyde (1) and from 4-(methylsulfonyl)benzaldehyde (2) were capable of inhibiting the AChE activity in vitro. Three compounds, two with a propylpiperidine (1b and 2b) moiety and one with a 3-(diethylamino)propyl (1c) moiety showed IC50 values of 13.81 μM, and 3.13 μM (1b), 55.36 μM and 44.33 μM (1c) for cerebral cortex and hippocampus, respectively, and 3.11 μM for both (2b). Enzyme kinetics revealed that the type of AChE inhibition was mixed. Compound 1b inhibited the G1 and G4 AChE isoforms, while compounds 1c and 2b selectively inhibited the G4 isoform. Molecular docking showed a possible three-dimensional fit into the enzyme. Our findings showed that these thiazolidin-4-ones, especially those containing the propylpiperidine core, have a potential cholinesterase inhibitory activity and can be considered good candidates for future Alzheimer’s therapy.
References
Gold P (2003) Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem 80:194–210
Deiana S, Platt B, Riedel G (2011) The cholinergic system and spatial learning. Behav Brain Res 10:389–411
Haam J, Yakel J (2017) Cholinergic modulation of the hippocampal region and memory function. J Neurochem 142:111–121
Dvir H, Silman I, Harel M, Rosenberry T, Sussman J (2010) Acetylcholinesterase: from 3d structure to function. Chem Biol Interact 187:10–22
Rakonczay Z, Horath Z, Juhász A, Kálmán J (2005) Peripheral cholinergic disturbances in Alzheimer’s disease. Chem Biol Interact 157–158:233–238
Sussan JL, Harel M, Silman I (1993) Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs. Chem Biol Interact 87:187–197
Das A, Dikshi M, Nath C (2005) Role of molecular isoforms of acetylcholinesterase in learning and memory functions. Pharmacol Biochem Behav 81:89–99
Mufson E, Counts S, Perez S, Ginsberg S (2008) Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications. Expert Rev Neurother 8:1703–1718
Ferreira-Vieira T, Guimaraes I, Silva F, Ribeiro F (2016) Alzheimer’s disease: targeting the cholinergic system. Curr Neuropharmacol 14:101–115
Mohammad D, Chan P, Bradley J, Lancot K, Herrmann N (2017) Acetylcholinesterase inhibitors for treating dementia symptoms—a safety evaluation. Expert Opin Drug Saf 16:1009–1019
Du X, Wang X, Geng M (2018) Alzheimer’s disease hypothesis and related therapies. Transl Neurodegener 30:1–7
Kumar D, Gupta S, Ganeshpurkar A, Gutti G, Krishnamurthy S, Modi G, Singh S (2018) Development of piperazinediones as dual inhibitor for treatment of Alzheimer’s disease. Eur J Med Chem 150:87–101
Manjal SK, Kaur R, Bathia R, Kumar K, Singh V, Shankar R, Kaur R, Rawal RK (2017) Synthetic and medicinal perspective of thiazolidinones: a review. Bioorg Chem 75:406–423
Silva DS, Silva CHE, Soares MSP, Azambuja JH, Carvalho T, Zimmer G, Frizzo CP, Braganhol E, Spanevello RM, Cunico W (2016) Thiazolidin-4-ones from 4-(methylthio)benzaldehyde and 4-(methylsulfonyl)benzaldehyde: synthesis, antiglioma activity and cytotoxicity. Eur J Med Chem 124:574–582
Berwaldt GA, Gouvêa DP, Silva DS, Neves AM, Soares MSP, Azambuja JH, Siqueira GM, Spanevello RM, Cunico W (2019) Synthesis and biological evaluation of benzothiazin-4-ones: a possible new class of acetylcholinesterase inhibitors. J Enzym Inhibit Med Chem 34:197–203
Ganellin C (2011) Personal reflections on Sir James Black (1924–2010) and histamine. Inflamm Res 60:103–110
Stapleton MP (1997) Sir james black and propranolol: the role of the basic sciences in the history of cardiovascular pharmacology. Tex Heart Inst J 24:336–342
Walker MJ (2011) The major impacts of James Black’s drug discoveries on medicine and pharmacology. Trends Pharmacol Sci 32:183–188
Ellman G, Courtney D, Andres V, Featherstone R (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Böyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97:77–89
Fitzgerald B, Costa L (1993) Modulation of muscarinic receptors an acetylcholinesterase activity in lymphocytes and brain areas following repeated organophosphate exposure in rats. Fund Appl Toxicol 20:210–216
Tanchuk V, Tanin V, Vovk A, Poda G (2016) New improved hybrid scoring function for molecular docking and scoring based on AutoDock and AutoDock Vina. Chem Biol Drug Des 87:618–625
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew R, Goodsell D, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785–2791
Seus V, Silva JL, Gomes G, Silva PE, Werhli A, Machado K (2016) A framework for virtual screening. In: Proceedings of the 31st annual ACM symposium on applied computing, pp 31–36
Preston A, Eihenbaum H (2013) Interplay of hippocampus and prefrontal cortex in memory. Curr Biol 23:764–773
Snape MF, Misra A, Murray TK, De Souza RJ, Williams JL, Cross AJ, Green AR (1999) A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacol 38:181–193
Siek G, Katz LS, Fishman EB, Korosi TS, Marquis JK (1990) Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain. Biol Psychol 27:573–580
Weinstock M (1999) Selectivity of cholinesterase inhibition. CNS Drug 12:307–323
Rakonczay Z (2003) Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer’s disease brain. Acta Biol Hung 54:183–189
Zhao Q, Tang XC (2002) Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. Eur J Pharmacol 29:101–107
Polanka M (2014) Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity. Int J Mol Sci 15:9809–9825
Nizri E, Hamra-Amitay Y, Sicsic C, Lavon L, Brenner T (2006) Anti-inflammatory properties of cholinergic up-regulation: a new role of acetylcholinesterase inhibitors. Neuropharmacology 50:540–547
Iyer P, Bolla J, Kumar V, Gill MS, Sobhia ME (2015) In silico identification of targets for a novel scaffold, 2-thiazolylimino-5-benzylidin-thiazolidin-4-one. Mol Divers 19:855–870
Acknowledgements
This research was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico and Fundação de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS - PRONEM processo: 16/2551-0000 2452). This study was financed in part by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES)—Finance code 001. W.C. and R.M.S are recipients of CNPq fellowship.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
da Silva, D.S., Soares, M.S.P., Martini, F. et al. In Vitro Effects of 2-{4-[Methylthio(methylsulfonyl)]phenyl}-3-substitutedthiazolidin-4-ones on the Acetylcholinesterase Activity in Rat Brain and Lymphocytes: Isoform Selectivity, Kinetic Analysis, and Molecular Docking. Neurochem Res 45, 241–253 (2020). https://doi.org/10.1007/s11064-019-02929-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-019-02929-8